Results 51 to 60 of about 8,196 (186)

Evaluation of the Enhanced Recovery After Surgery (ERAS) Guidance for Patients With Spinal Metastasis

Orthopaedic Surgery, Volume 18, Issue 3, Page 385-401, March 2026.
The flow diagram of study. ABSTRACT Surgery continues to remain the most effective treatment for spinal metastasis (SM). As the number of surgeries continues to grow, the need for consensus guidelines for optimal perioperative care is imperative. Enhanced recovery after surgery (ERAS) protocols were created for this purpose. The objective of this study
Fanjie Li, Wenlong Yu, Changchang Shen, Jinxin Luo, Zhibin Li, Qiang Gao, Chengchun Jin, Tao Li, Quan Huang, Shuqiang Wang, Peilin Chu, Mengchen Yin   +11 more
wiley   +1 more source

Efficacy and safety of teclistamab in triple‐class exposed relapsed/refractory multiple myeloma: Pooled findings from three clinical cohorts and a retrospective cohort

Cancer, Volume 132, Issue 1, 1 January 2026.
Abstract Background Teclistamab is the first approved bispecific antibody targeting B‐cell maturation antigen. It has demonstrated rapid, deep, durable responses with manageable safety in patients with triple‐class exposed relapsed/refractory multiple myeloma (TCE RRMM).
Thomas G. Martin, María‐Victoria Mateos, Jun Ho Yi, Niels W. C. J. van de Donk, Zhen Cai, Weijun Fu, Alfred L. Garfall, Shinsuke Iida, Sung‐Hoon Jung, Yoshiaki Kuroda, Ting Niu, Ajay K. Nooka, Chang‐Ki Min, Surbhi Sidana, Katherine Chastain, Margaret Doyle, Kazuko Nishikawa, Xiaohong Wang, Yang Song, Hiroshi Yamazaki, Yusuke Izumi, Jianmin Zhuo, Angeline Zhu, Dok Hyun Yoon, Juan Du, Tadao Ishida   +25 more
wiley   +1 more source

What Is Your Diagnosis? Submandibular Mass in a Dog

Veterinary Clinical Pathology, EarlyView.
Whitney K. Chandler, Barbara E. Powers, Devorah M. Stowe, Nancy B. Collicutt   +3 more
wiley   +1 more source

Daratumumab‐based quadruplet for patients with extramedullary multiple myeloma: Results from the Phase II prospective EMN19 study

HemaSphere, Volume 10, Issue 1, January 2026.
ABSTRACT Novel therapies are needed for patients with multiple myeloma (MM) and extramedullary plasmacytomas. The prospective, Phase II EMN19 study assessed the efficacy and safety of daratumumab plus bortezomib, cyclophosphamide, and dexamethasone (DaraVCD) in 40 patients with newly diagnosed MM (NDMM; n = 29) or at first relapse (RMM; n = 11) and ...
Meral Beksac, Tulin Fıratlı Tuglular, Francesca Gay, Roberto Mina, Eirini Katodritou, Ali Unal, Michele Cavo, Guner Hayri Ozsan, Vincent H. J. van der Velden, Berna H. Beverloo, Michael Vermeulen, Mark van Duin, Guldane Cengiz Seval, Omur Gokmen Sevindik, Serena Merante, Kyriaki Manousou, Peter Sonneveld, Elena Zamagni, Evangelos Terpos   +18 more
wiley   +1 more source

Multiple Extramedullary Plasmacytoma with Lytic Bony Lesions: A Rare Case Report

Case Reports in Medicine, 2013
Objective. Multiple extramedullary plasmacytoma lesions involving subcutaneous tissue, breast, mediastinal tissue, spleen, and soft tissue of pelvic region along with multiple bones plasmacytomas without marrow plasmacytosis are a very rare presentation.
Akhlak Hussain, Mohinder Singh, Kuldip Singh, Harjot Bagga   +3 more
doaj   +1 more source

A Case of Maxillary Sinus Plasmacytoma With the Rare Manifestation of Oroantral Fistula: A Case Report

Case Reports in Dentistry, Volume 2026, Issue 1, 2026.
Background Extramedullary plasmacytoma (EMP) is an uncommon neoplastic proliferation of monoclonal plasma cells, most frequently arising within the upper respiratory tract. Involvement of the maxillary sinus is rare, and presentation as a chronic oroantral fistula (OAF) is exceptionally unusual, often complicating timely diagnosis and management.
Moosa Mahmoudi, Aida Karagah, Seyed Ghasem Mirbaba, Sarina Hassanpour Dargah, Hannah Wesley   +4 more
wiley   +1 more source

A Rare Case of Concurrent Urinothorax and Myelomatous Pleural Effusion

Case Reports in Pulmonology, Volume 2026, Issue 1, 2026.
Introduction Myelomatous pleural effusion (MPE) is a rare complication of multiple myeloma, occurring in < 1% of cases and associated with poor prognosis. Urinothorax, another rare cause of pleural effusion, results from urine leakage into the pleural cavity, typically due to obstructive uropathy or trauma.
Prachi Bhanvadia, Aarish Lalani, Sara Samadami, Amandeep Bawa, Laxman Wagle, Inger F. Oey   +5 more
wiley   +1 more source

Epigenetics in B‐CLL

International Journal of Genomics, Volume 2026, Issue 1, 2026.
B‐cell chronic lymphocytic leukemia (B‐CLL) is the most common hematological malignancy in adults. Its clinical course is heterogeneous, ranging from indolent forms with slow progression to aggressive variants refractory to conventional treatment.
Alexandra Chu, Flavia Soto, Rodrigo Hurtado, Carlos A. Tirado, Priyanka Sharma   +4 more
wiley   +1 more source

Rare Presentation of Primary Extramedullary Plasmacytoma as Lip Lesion

Case Reports in Oncological Medicine, 2017
Malignant plasma cell proliferation can be presented as part of disseminated disease of multiple myeloma, as solitary plasmacytoma of bone, or in soft tissue as extramedullary plasmacytoma. Extramedullary plasmacytomas represented approximately 3% of all
Mali Him, Maggie Meier, Vikas Mehta
doaj   +1 more source

Synchronous infiltrating ductal carcinoma and primary extramedullary plasmacytoma of the breast

World Journal of Surgical Oncology, 2009
Background Extramedullary plasmacytomas are seldom solitary and usually progress to diffuse myelomatosis. Plasmacytomas of the breast are rare, especially when not associated multiple myeloma.
Liu Yan-Xue, Kang Hong-Gang, Cao Shui, Ren Xiu-Bao   +3 more
doaj   +1 more source